Panangin

Panangin is a drug intended for the treatment of water and electrolyte imbalances and arrhythmias caused by hypokalemia. The drug contains potassium and magnesium asperagine, which helps regulate the level of electrolytes in the body and helps normalize heart function.

Manufacturers: Gedeon Richter A.o. (Hungary).

Release form: injection solution, as well as film-coated tablets. The instructions indicate contraindications, such as renal and heart failure, as well as restrictions on the use of Panangin with increased levels of potassium and magnesium in the blood and acute and chronic renal failure.

Active ingredient of Panangin: Potassium and magnesium aspergaine, help restore the natural functioning of various organs and systems of the body, improve blood supply to the brain, and reduce the risk of stroke. This drug is prescribed by cardiologists to eliminate arrhythmia and hypokalemic disorders.

Panangin is a drug for regulating water-electrolytic balance, which is a combination of potassium and magnesium, and is used for arrhythmias caused by hypopotassium, as well as for intoxication with cardiac glycoside drugs or ventricular extrasystole.

The production of this drug is carried out by the Gedeon Richteri company; it has two types of pharmacological forms - injectable and tablet. The tablets have different compositions, therefore, they are separate individual medicines. The standard doses and timing of use are determined by the doctor. The use of Panangin is limited by a number of contraindications and side effects. The medicine should not be taken in case of hypercalisis, impaired renal function, heart block, or hypersensitivity to one of the components of the drug. When taking Panangin, it is necessary to monitor the level of electrolytes in the blood, but an overdose of this drug is possible only with massive intake of large doses, it is expressed in the form of conduction disturbances and cardiac arrhythmia, requiring immediate treatment.